Opinion

Why accreditation?

New reasons why the announced death of this profession will always be premature

What you need to know about the current specialty pharmacy landscape

Things to know about the increasingly popular--and competitive--orphan drug space

PwC's annual forecast of the year's most important healthcare trends

The Health & Personal Care Logistics Conference brings industry leaders together

The Drug Quality and Security Act will change industry for the better

Retailers, distributors and manufacturers are being affected by federal rules on durable medical equipment (DME)

Industry response may be to keep more innovations as trade secrets

The perfect pharmaceutical product would be a pill or injection that, once taken, has a near-immediate beneficial effect.

What are the risks of future 'pay for delay' settlements between branded and generic manufacturers?

Regardless of how pending US legislation is resolved, manufacturers need to move ahead

Life sciences companies - including mid-market ones - are finding value in an outsourced service

The full range of healthcare manufacturers should have a unified voice

Continuing problems with compounding pharmacies muddle biopharma’s future direction

Oncology is the market for today's pipeline products. Here's why the community setting needs to be preserved as a primary site of care to administer those products

In the race to improve product performance, not enough attention is paid to 'who's actually going to switch?'

Like the other war on drugs, there's no end in sight

When drugs in development today hit the marketplace in 2020, they will need evidence of economic and clinical value results to be commercially successful

Pharmaceutical marketing is now operating in a new landscape--the Economy of Attention

Abbott's spinout of AbbVie offers lessons

Applying the managed services model to commercial operations can result in dramatic savings as pharma companies globalize